pabs, thx for the summary. I agree with your $10B valuation. But you need to put a time qualifier on that one. I would say by 2025. Or do you mean fair value today?
Talga is subject to quite a lot of execution risk. The fundamentals of the company are stellar, but we dont know the contents and negotiation proceedings of any of the JV. I think this will have the strongest impact on the share price. Off-take agreement details as well, but I dont think there is a lot of wiggle room that would move the share price. Only the existence and offtake volume would matter.
Your point 4 is the demand side. We all know demand is through the roof and I would absolutely love for Talga to produce that much. To confirm, you mean 500ktpa Talnode-C production, right? But so far, I have not seen any way, plan or rumor how they would achieve that. At moment, we are sitting at about 100ktpa Talnode-C production by 2025.
We are not really going to decipher any future development based on currently available information.
- Forums
- ASX - By Stock
- TLG
- Talga Valuation.
Talga Valuation., page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLG (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.5¢ |
Change
-0.010(1.80%) |
Mkt cap ! $206.9M |
Open | High | Low | Value | Volume |
56.0¢ | 57.5¢ | 54.0¢ | $444.8K | 802.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 32712 | 54.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 35434 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 32712 | 0.545 |
5 | 45824 | 0.540 |
3 | 44869 | 0.530 |
1 | 10 | 0.525 |
7 | 325884 | 0.520 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 35434 | 1 |
0.570 | 15190 | 2 |
0.575 | 23000 | 1 |
0.580 | 50000 | 2 |
0.585 | 10000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
TLG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online